535 related articles for article (PubMed ID: 30619268)
41. CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6.
Tanida S; Yoshitomi H; Nishitani K; Ishikawa M; Kitaori T; Ito H; Nakamura T
Cytokine; 2009 Aug; 47(2):112-8. PubMed ID: 19535263
[TBL] [Abstract][Full Text] [Related]
42. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients.
Lisignoli G; Piacentini A; Cristino S; Grassi F; Cavallo C; Cattini L; Tonnarelli B; Manferdini C; Facchini A
J Cell Physiol; 2007 Mar; 210(3):798-806. PubMed ID: 17133360
[TBL] [Abstract][Full Text] [Related]
43. Distinct
Baricza E; Marton N; Királyhidi P; Kovács OT; Kovácsné Székely I; Lajkó E; Kőhidai L; Rojkovich B; Érsek B; Buzás EI; Nagy G
Front Immunol; 2018; 9():606. PubMed ID: 29670615
[TBL] [Abstract][Full Text] [Related]
44. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.
Miranda-Carús ME; Benito-Miguel M; Balsa A; Cobo-Ibáñez T; Pérez de Ayala C; Pascual-Salcedo D; Martín-Mola E
Arthritis Rheum; 2006 Apr; 54(4):1151-64. PubMed ID: 16575870
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
[TBL] [Abstract][Full Text] [Related]
46. Synoviocytes-derived Interleukin 35 Potentiates B Cell Response in Patients with Osteoarthritis and Rheumatoid Arthritis.
Kam NW; Liu D; Cai Z; Mak WY; Wong CK; Chiu KH; Wong KY; Tsang WL; Tam LS
J Rheumatol; 2018 Apr; 45(4):563-573. PubMed ID: 29247146
[TBL] [Abstract][Full Text] [Related]
47. CCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis.
Van Raemdonck K; Umar S; Palasiewicz K; Volkov S; Volin MV; Arami S; Chang HJ; Zanotti B; Sweiss N; Shahrara S
Cell Mol Life Sci; 2020 Apr; 77(7):1387-1399. PubMed ID: 31342120
[TBL] [Abstract][Full Text] [Related]
48. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis.
Kim KW; Kim HR; Kim BM; Cho ML; Lee SH
Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732
[TBL] [Abstract][Full Text] [Related]
49. [Molecular mechanisms of bone destruction in rheumatoid arthritis].
Nanki T
Clin Calcium; 2007 Apr; 17(4):510-6. PubMed ID: 17404479
[TBL] [Abstract][Full Text] [Related]
50. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis.
Miller LE; Grifka J; Schölmerich J; Straub RH
J Rheumatol; 2002 Mar; 29(3):427-35. PubMed ID: 11908553
[TBL] [Abstract][Full Text] [Related]
51. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion.
Chizzolini C; Chicheportiche R; Alvarez M; de Rham C; Roux-Lombard P; Ferrari-Lacraz S; Dayer JM
Blood; 2008 Nov; 112(9):3696-703. PubMed ID: 18698005
[TBL] [Abstract][Full Text] [Related]
52. Rheumatoid arthritis fibroblast-like synoviocytes co-cultured with PBMC increased peripheral CD4
Tang Y; Wang B; Sun X; Li H; Ouyang X; Wei J; Dai B; Zhang Y; Li X
Clin Exp Immunol; 2017 Dec; 190(3):384-393. PubMed ID: 28833034
[TBL] [Abstract][Full Text] [Related]
53. Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA).
Yoon BR; Yoo SJ; Choi Yh; Chung YH; Kim J; Yoo IS; Kang SW; Lee WW
PLoS One; 2014; 9(10):e109775. PubMed ID: 25329467
[TBL] [Abstract][Full Text] [Related]
54. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
55. Tumour necrosis factor α augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression.
Oi K; Tokunaga T; Kuranobu T; Yukawa K; Kohno H; Yoshida Y; Mokuda S; Hirata S; Sugiyama E
Clin Exp Immunol; 2019 Jun; 196(3):392-402. PubMed ID: 30724348
[TBL] [Abstract][Full Text] [Related]
56. Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts.
Pathak JL; Bravenboer N; Verschueren P; Lems WF; Luyten FP; Klein-Nulend J; Bakker AD
Osteoporos Int; 2014 Oct; 25(10):2453-63. PubMed ID: 25027107
[TBL] [Abstract][Full Text] [Related]
57. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.
Eyerich S; Eyerich K; Pennino D; Carbone T; Nasorri F; Pallotta S; Cianfarani F; Odorisio T; Traidl-Hoffmann C; Behrendt H; Durham SR; Schmidt-Weber CB; Cavani A
J Clin Invest; 2009 Dec; 119(12):3573-85. PubMed ID: 19920355
[TBL] [Abstract][Full Text] [Related]
58. Effector T helper cell populations are elevated in the bone marrow of rheumatoid arthritis patients and correlate with disease severity.
Li S; Yin H; Zhang K; Wang T; Yang Y; Liu X; Chang X; Zhang M; Yan X; Ren Y; Pan W; Zhang L
Sci Rep; 2017 Jul; 7(1):4776. PubMed ID: 28684770
[TBL] [Abstract][Full Text] [Related]
59. IL-22 Produced by T helper Cell 22 as a New player in the Pathogenesis of Immune Thrombocytopenia.
Azizi G; Yazdani R; Hamid KM; Razavi A; Mirshafiey A
Endocr Metab Immune Disord Drug Targets; 2015; 15(3):242-50. PubMed ID: 25824530
[TBL] [Abstract][Full Text] [Related]
60. Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells.
Davis LS; Cush JJ; Schulze-Koops H; Lipsky PE
Arthritis Res; 2001; 3(1):54-64. PubMed ID: 11178127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
